Press Releases
Aptar CSP Technologies’ Dual-Active Material Science Technology Simultaneously Controls Moisture and Oxygen for Pharmaceutical Drugs and Medical Devices
Dual-active material science solution is ideal for sensitive formulations
Auburn, AL, July 8, 2025 – Aptar CSP Technologies, part of AptarGroup, Inc. and a leader...
Interviews
Trend Forecasting: Insights from Dr. Oliver Okle
Dr. Oliver Okle is a product and service manager at Vetter
The global CDMO market is projected to more than double from $161 billion in...
News
Merck to Acquire Verona for $10B, COPD Drug in Focus
Merck has pulled off another acquisition that happens to fit in its sweet spot, says Rob Davis, its CEO. As Merck acquires Verona Pharma...
Press Releases
datma Launches Federated Biomarker Explorer with Free Access to Help Pharma Validate Real-World Data Coverage
Pharma teams can now assess biomarker coverage across datma's federated network with no cost, contracts, or IT support required.
datma, a leader in federated real-world...
News
PDUFA Crucial for Biopharmaceutical Innovation in the US
The United States happens to lead the world when it comes to the discovery and development of innovative medicines. All thanks largely to a...
News
The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era
Over the past few decades, the concept of self-care has evolved dramatically. Gone are the days when occasional spa days or simple checklists of...
Press Releases
Infudopa SubC Parkinsons Therapy: Neuraxpharm-Dizlin Deal
Neuraxpharm Group (“Neuraxpharm”), a leading European specialty pharmaceutical company dedicated to central nervous system (CNS) disorders, and Dizlin Pharmaceuticals AB (“Dizlin”), a Swedish R&D...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read